UPDATE: Evaluating Plastic Syringes Made in China for Potential ...

Español 简体中文 (Simplified Chinese) Tagalog

If you want to learn more, please visit our website Kush.

Date Issued: March 19,

The U.S. Food and Drug Administration (FDA) is providing an update on our ongoing evaluation of quality and performance issues related to plastic syringes made in China, and announcing additional recommendations and actions the FDA is taking to address these issues. 

In November , the FDA informed consumers, health care providers, and health care facilities that the FDA is evaluating the potential for device failures (such as leaks, breakage, and other problems) with plastic syringes manufactured in China, that are used for injecting fluids into, or withdrawing fluids from, the body. We had received information about quality issues associated with several China-based manufacturers of syringes. The issue does not include glass syringes, pre-filled syringes, or syringes used for topical purposes.

On March 18, , the FDA issued warning letters that describe violations related to the sale and distribution of unauthorized plastic syringes made in China that have not been cleared or approved by the FDA for sale or distribution in the U.S. to the following three entities:

• Jiangsu Shenli Medical Production Co. Ltd. (China-based manufacturer of plastic syringes) 
• Medline Industries, LP (firm marketing and distributing plastic syringes made in China within the U.S.)
• Sol-Millennium Medical, Inc. (firm marketing and distributing plastic syringes made in China within the U.S.)

The warning letters for Medline Industries, LP and Sol-Millennium Medical, Inc. also concern violations related to quality system regulations for syringe products. The FDA expects these entities to fully address the violations described in the warning letters. In addition, we are actively evaluating quality issues and performance testing failures with plastic syringes made by Jiangsu Caina Medical Co Ltd., a China-based manufacturer cited in the warning letter issued to Medline Industries, LP. The FDA will take additional steps as appropriate.

We remain concerned that certain syringes manufactured in China may not provide consistent and adequate quality or performance, and our evaluation is ongoing. This is an evolving situation, and we will continue to keep the public informed as new or additional information becomes available.

Recommendations for U.S. suppliers of plastic syringes, consumers, health care providers and facilities (Updated August 16, )

Until further notice and because of potential quality and performance issues,

• Immediately transition away from using plastic syringes manufactured by the following China-based manufacturers, unless use of these syringes is absolutely necessary until you can complete the transition to syringes that are not manufactured in China:
  • Jiangsu Caina Medical Co., Ltd.
  • Jiangsu Shenli Medical Production Co., Ltd.
  • Shanghai Kindly Enterprise Development Group Co., Ltd
• Immediately transition away from using enteral syringes manufactured by Jiangsu Shenli Medical Production Co., Ltd. unless use of these syringes is absolutely necessary until you can complete the transition to enteral syringes manufactured by a different manufacturer.
  • The FDA is not recommending a transition away from all enteral syringes manufactured in China at this time.

For all other plastic syringes made in China, while the FDA’s evaluation remains ongoing, we continue to recommend the following:

• Check the manufacturing location for syringes you use or have in your inventory by reviewing the labeling, outer packaging, or contacting your supplier or group purchasing organization.
• Use syringes not manufactured in China, if possible. At this time, glass syringes, pre-filled syringes, or syringes used for topical purposes are not included.
• If you only have syringes manufactured in China, then continue to use them as needed until you are able to use alternative syringes and closely monitor for leaks, breakage, and other problems. 
• Report any issues with syringes to the FDA.

Device Description

Generally, a syringe is used to inject fluid into, or withdraw fluid from, the body and can be used in a variety of clinical and home health settings. Some syringes may also be used with infusion pumps to deliver fluids into the body in a controlled manner.

For more information, please visit 1ml Luer Lock Glass Syringes Supplier.

Enteral syringes are used to deliver nutritional fluid to the gastrointestinal system of a patient who is physically unable to eat and swallow. Enteral syringes are also used to deliver medications orally or to a patient’s gastrointestinal system via a feeding tube. Some enteral syringes may be used with enteral feeding pumps to deliver nutritional fluid or medication to a patient’s enteral feeding tube in a controlled manner.

Potential Syringe Failures

The FDA will continue our extensive efforts to evaluate problems with plastic syringes manufactured in China, including facility inspections, examining products at the border and detaining them as appropriate, laboratory testing of syringes, and working with manufacturers, when applicable, to ensure adequate corrective actions are taken. We will also continue to monitor all available sources of data for reports of problems with syringes manufactured in China, such as leaks, breakage, and other problems after manufacturers made changes to the syringe dimensions. These quality issues may affect the performance and safety of the syringes including their ability to deliver the correct dose of medication when used alone or with other medical devices such as infusion pumps.  

FDA Actions

The FDA believes that the supply and manufacturing capacity of plastic syringes made in countries other than China, including domestic manufacturing, is adequate to support current health care demand.

We will continue to work with stakeholders, including other federal agencies, medical device manufacturers, and health care organizations to help ensure the safety of syringes being used in the U.S. In addition, we will continue our efforts to evaluate problems with syringes made in China and keep the public informed as new or additional information becomes available.

Related Warning Letters

Related Imports Alerts

Timeline of FDA Communication Updates

Related Recalls

• Related Recalls - Plastic Syringes Made in China for Potential Device Failures [Español] [简体中文 (Simplified Chinese)] [Tagalog]

Reporting Problems to the FDA

If you think you had a problem with a syringe, or any medical device, the FDA encourages you to report the problem through the MedWatch Voluntary Reporting Form.

Health care personnel employed by facilities that are subject to the FDA's user facility reporting requirements should follow the reporting procedures established by their facilities.

If you are experiencing supply issues for syringes, or other devices, you may contact the FDA about a medical device supply chain issue. Reporting supply chain issues to the FDA helps inform actions to prevent shortages and protect patient health.

Questions?

Select sizes of Fortuna syringes are now manufactured in India.  These syringes are interchangeable within their country of origin.  Italian sourced syringes are not interchangeable with the Made in India syringes.  Country of Origin is clearly noted on each box.  Manufacturer's numbers have not changed.  As of March , the following sizes have been converted to the Indian manufacturing facility:

Glass Luer Slip - 1mL, 3mL, 100mL
Metal Luer Lock - 2mL, 100mL

Buy this item often? Add it to your favorites for quick access in the future from your account settings.
You will need to sign-in to your account to add to your favorites.

If you want to learn more, please visit our website Cannabis Concentrate Packaging.